Skip to content
10-Q

Quarterly Report

ENZO BIOCHEM, INC.

0001213900-24-109311

← back to feed
Filed
Dec 16, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Dec 12, 2024 52.24M sh
Shares Diluted Q1 2025 · Oct 31, 2024 52.24K sh
Shares Diluted Q1 2025 · Oct 31, 2023 50.18K sh
Operating Cash Flow Q1 2025 · Oct 31, 2024 −$8.99M
Operating Cash Flow Q1 2025 · Oct 31, 2023 −$13.37M
Long Term Debt Q1 2025 · Oct 31, 2024 $155K
Long Term Debt Q1 2025 · Jul 31, 2024 $189K
Cash And Equivalents Q1 2025 · Oct 31, 2024 $47.74M
Cash And Equivalents Q1 2025 · Jul 31, 2024 $52.37M
Stockholders Equity Q1 2025 · Oct 31, 2024 $47.66M
Stockholders Equity Q1 2025 · Jul 31, 2024 $56.11M
Stockholders Equity Q1 2025 · Oct 31, 2023 $74.28M
Stockholders Equity Q1 2025 · Jul 31, 2023 $78.46M
Current Liabilities Q1 2025 · Oct 31, 2024 $23.4M
Current Liabilities Q1 2025 · Jul 31, 2024 $24.79M
Total Liabilities Q1 2025 · Oct 31, 2024 $27.63M
Total Liabilities Q1 2025 · Jul 31, 2024 $29.65M
Current Assets Q1 2025 · Oct 31, 2024 $59.66M
Current Assets Q1 2025 · Jul 31, 2024 $70.03M
Total Assets Q1 2025 · Oct 31, 2024 $75.29M
Total Assets Q1 2025 · Jul 31, 2024 $85.76M
Eps Diluted Q1 2025 · Oct 31, 2024 −$0.07
Eps Diluted Q1 2025 · Oct 31, 2023 −$0.13
Eps Basic Q1 2025 · Oct 31, 2024 −$0.07
Eps Basic Q1 2025 · Oct 31, 2023 −$0.13
Sga Expense Q1 2025 · Oct 31, 2024 $4.88M
Sga Expense Q1 2025 · Oct 31, 2023 $7.01M
Rd Expense Q1 2025 · Oct 31, 2024 $562K
Rd Expense Q1 2025 · Oct 31, 2023 $849K
Net Income Q1 2025 · Oct 31, 2024 −$3.38M
Net Income Q1 2025 · Oct 31, 2023 −$6.62M
Operating Income Q1 2025 · Oct 31, 2024 −$3.62M
Operating Income Q1 2025 · Oct 31, 2023 −$5.48M
Cost Of Revenue Q1 2025 · Oct 31, 2024 $3.68M
Cost Of Revenue Q1 2025 · Oct 31, 2023 $4.35M
Revenue Q1 2025 · Oct 31, 2024 $6.21M
Revenue Q1 2025 · Oct 31, 2023 $7.81M